Instituto Politecnico Nacional Reports Findings in Chagas Disease (Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening)

Prensa/medios de comunicación

Período9 feb. 2024

Cobertura de los medios

1

Cobertura de los medios